Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Cash flows from operating activities:          
Net loss     $ (87,382) $ (40,820)  
Adjustments to reconcile net loss to cash used in operating activities:          
Depreciation     331 122 $ 161
Share-based compensation expense     2,352 2,633  
Interest on short-term investments     (136)    
Non-cash loss on short-term investments     353    
Amortization of debt discount and deferred financing costs     3,636 7,818  
Financing transaction costs included in financing activities   $ 685   2,815  
Adjustments to fair value of derivatives $ (9,783) 644 64,526 (1,023)  
Other     2,311 907  
Changes in operating assets and liabilities:          
Prepaid expenses and other current assets     1,516 3,593  
Accounts payable     (540) (12,879)  
Accrued expenses     (137) (10,229)  
Income taxes     (397) (89)  
Other liabilities     (689) (683)  
Net cash used in operating activities     (13,383) (45,497)  
Cash flows from investing activities:          
Purchases of property and equipment     (48) (11)  
Purchases of short-term investments     (60,081)    
Proceeds from sale of ST investments     10,000    
Net cash used by investing activities     (50,129) (11)  
Cash flows from financing activities:          
Proceeds from PPP Loan       744  
Repayments of long-term debt     (4,887) (4,655)  
Proceeds from private placement and rights offering, net of transactions costs       44,699  
Proceeds from issuance of ordinary shares, net of transaction costs     89,643 8,560  
Net cash provided by financing activities     84,756 49,348  
Effect of exchange rates on cash and cash equivalents     (14) (35)  
Net increase in cash, cash equivalents and restricted cash     21,230 3,805  
Cash, cash equivalents and restricted cash, at beginning of period     14,816 4,891 4,891
Cash, cash equivalents and restricted cash, at end of period $ 36,046 $ 8,696 36,046 8,696 $ 14,816
Supplemental Disclosure of Cash Flow Information:          
Income tax paid - US     397 89  
Interest paid     361 767  
Exchangeable Notes          
Adjustments to reconcile net loss to cash used in operating activities:          
Interest on exchangeable notes - non-cash     $ 873 $ 2,338